1-20 of 34
Marcel Nijland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Favorable Outcome of Abbreviated R-CHOP in Patients with Primary Testicular Lymphoma

Diana Al-Sarayfi, Mirian Brink, Mar Bellido, Wouter Plattel, Gerwin A. Huls, Marcel Nijland
Journal: Blood
Blood (2023) 142 (Supplement 1): 3115.
https://doi.org/10.1182/blood-2023-186261
Published: 2023
Journal Articles

Patients with Relapsed Large B-Cell Lymphoma after 12 Months Have a Similarly Poor Prognosis As Patients with a Relapse before 12 Months

Hilde T Van Der Galien, Hilde AM Kooistra, Robby Kibbelaar, Nic JGM Veeger, Marcel Nijland, Geert A. Huls, Tom Van Meerten, Rozemarijn S Van Rijn
Journal: Blood
Blood (2023) 142 (Supplement 1): 444.
https://doi.org/10.1182/blood-2023-185993
Published: 2023
Journal Articles

No Discernable Dysfunction of Peripheral T-Cells and NK-Cells Despite Distinct Phenotypes in MYC Rearranged Versus Non Rearranged B-Cell Lymphoma Patients

A. Vera de Jonge, Carolien Duetz, Wassilis S.C Bruins, Charlotte L.B.M. Korst, Rosa Rentenaar, Meliha Cosovic, Merve Eken, Inoka Twickler, Marcel Nijland, Marjolein Van Der Poel, Koen de Heer, Clara Klerk, Leonie Strobbe, Margriet Oosterveld, Rinske Boersma, Harry R. Koene, Erik van Werkhoven, Martine E.D. Chamuleau, Tuna Mutis
Journal: Blood
Blood (2023) 142 (Supplement 1): 1653.
https://doi.org/10.1182/blood-2023-180734
Published: 2023
Journal Articles

Glofitamab (Glofit) Plus R-CHOP Has a Favorable Safety Profile and Induces High Response Rates in Patients with Previously Untreated (1L) Large B-Cell Lymphoma (LBCL) Defined As High Risk By Circulating Tumor DNA (ctDNA) Dynamics: Preliminary Safety and Efficacy Results

Lorenzo Falchi, Fabrice Jardin, Corinne Haioun, Tomasz Wrobel, Judit Mészáros Joergensen, Mariana Bastos-Oreiro, Eric Mou, Joaquin Martinez-Lopez, L. Elizabeth Budde, Nancy L. Bartlett, Jan M. Zaucha, Alejandro Martin Garcia-Sancho, Rutanshu Shah, Nathan Rees, Ron McCord, Alexandra Bazeos, Maneesh Tandon, Michelle Doral, Ethan Troy-Barnes, Marcel Nijland
Journal: Blood
Blood (2023) 142 (Supplement 1): 858.
https://doi.org/10.1182/blood-2023-173953
Published: 2023
Journal Articles

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

A.Vera de Jonge, Marie José Kersten, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara Klerk, Yorick Sandberg, Rozemarijn S Van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Roel JW van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S.P Vermaat, Otto Visser, Josée M. Zijlstra, Henk Hofwegen, Helma G.J.M. Zanders, Liping P. Fu, Daphne De Jong, Marcel Nijland, Martine E.D. Chamuleau
Journal: Blood
Blood (2023) 142 (Supplement 1): 3090.
https://doi.org/10.1182/blood-2023-181707
Published: 2023
Journal Articles

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Fleur A De Groot, Jeanette K. Doorduijn, Mirian Brink, Ruben A.L. De Groen, Lorraine M. De Haan, Troy Noordenbos, Aniko Sijs-Szabo, King Hong Lam, Arjan Diepstra, Liane te Boome, Valeska Terpstra, Lara H. Böhmer, Josée M. Zijlstra, Lianne Koens, Marc Durian, Mirjam A. Oudshoorn, Hendrik Veelken, Marjolein W.M. Van Der Poel, Myrurgia Abdul Hamid, Wendy B.C. Stevens, J L.M van Rooij, Rimke Oostvogels, Karen J. Neelis, Michiel van den Brand, F.J. Sherida H. Woei-a-Jin, Thomas Tousseyn, Daan Dierickx, Patty M. Jansen, Marie Jose Kersten, Jacoline Bromberg, Marcel Nijland, Joost S.P. Vermaat
Journal: Blood
Blood (2022) 140 (Supplement 1): 369–371.
https://doi.org/10.1182/blood-2022-163244
Published: 2022
Journal Articles

Subcutaneous Epcoritamab with Rituximab + Lenalidomide in Patients with Relapsed or Refractory Follicular Lymphoma:Phase 1/2 Trial Update

Lorenzo Falchi, Pau Abrisqueta, Marcel Nijland, Sirpa Leppä, Martin Hutchings, Harald Holte, Reid W Merryman, Pieternella Lugtenburg, Sven de Vos, Chan Y. Cheah, Jacob Haaber Christensen, Luca Arcaini, Kristina Drott, Mats Hellström, Lori A. Leslie, Umberto Vitolo, Ali Rana, Aqeel Abbas, Liwei Wang, Minh Dinh, David Belada
Journal: Blood
Blood (2022) 140 (Supplement 1): 1464–1466.
https://doi.org/10.1182/blood-2022-158203
Published: 2022
Journal Articles

Outcome of Transformed Marginal Zone Lymphoma: A Population Based Study

Johanna A.A. Bult, Francien Huisman, Yujie Zhong, Nick Veltmaat, Sanne Tonino, Joost S.P. Vermaat, Martine E.D. Chamuleau, Arjan Diepstra, Wouter J. Plattel, Anke Van Den Berg, Mirian Brink, Marcel Nijland
Journal: Blood
Blood (2022) 140 (Supplement 1): 6514–6516.
https://doi.org/10.1182/blood-2022-166052
Published: 2022
Journal Articles

Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments

Troy Noordenbos, Fleur A De Groot, Ruben A.L. De Groen, Lorraine M. De Haan, Ricki T. Krog, Aniko Sijs-Szabo, Marieke Griffioen, Rosa de Groot, Mirjam H.M. Heemskerk, Marieke E. Ijsselsteijn, Valeska Terpstra, Marcel Nijland, Pim Mutseaers, Martine E.D. Chamuleau, Marie Jose Kersten, Arjan Diepstra, Judith Bovée, Patty M. Jansen, Noel F.C.C. De Miranda, Joost S.P. Vermaat
Journal: Blood
Blood (2022) 140 (Supplement 1): 164–165.
https://doi.org/10.1182/blood-2022-156103
Published: 2022
Journal Articles

Detection of Cell Free Tumor DNA in Plasma of Patients with Large B-Cell Lymphoma of the Sanctuary Sites By Digital Droplet PCR

Yujie Zhong, Geok Tan, Wouter J. Plattel, Johanna A.A. Bult, Nick Veltmaat, Joost L. Kluiver, Roelien Enting, Arjan Diepstra, Anke Van Den Berg, Marcel Nijland
Journal: Blood
Blood (2022) 140 (Supplement 1): 9516–9517.
https://doi.org/10.1182/blood-2022-166357
Published: 2022
Journal Articles

Subcutaneous Epcoritamab in Combination with Rituximab + Lenalidomide (R 2 ) for First-Line Treatment of Follicular Lymphoma: Initial Results from Phase 1/2 Trial

Lorenzo Falchi, Lori A. Leslie, David Belada, Katerina Kopeckova, Fritz Offner, Joshua Brody, Miguel Canales, Alejandro Martín García-Sancho, Marcel Nijland, P-O Andersson, Farrukh T. Awan, Jacob Haaber Christensen, Kristina Drott, Mats Hellström, Catharina Lewerin, Mayur Narkhede, Sylvia Snauwaert, Björn E Wahlin, Ali Rana, Aqeel Abbas, Liwei Wang, Minh Dinh, Joost S.P. Vermaat, Pau Abrisqueta
Journal: Blood
Blood (2022) 140 (Supplement 1): 1471–1473.
https://doi.org/10.1182/blood-2022-158232
Published: 2022
Journal Articles

Immune Profiling of Double and Triple Hit High Grade B Cell Lymphoma Patients Treated with DA-EPOCH Reveals Activation of T Cells and Reduced T Cell Exhaustion

A.Vera de Jonge, Carolien Duetz, Wassilis S.C. Bruins, Erik D. van Werkhoven, Marcel Nijland, Marjolein W.M. Van Der Poel, Koen de Heer, Clara P.W. Klerk, Yorick Sandberg, Rob Fijnheer, Pim Mutseaers, Djamila E. Issa, Lara H. Böhmer, Roel J.W. Van Kampen, Otto J. Visser, Daphne de Jong, Josée M. Zijlstra, Tuna Mutis, Martine E.D. Chamuleau
Journal: Blood
Blood (2022) 140 (Supplement 1): 9298–9299.
https://doi.org/10.1182/blood-2022-163068
Published: 2022
Journal Articles

Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA

Nick Veltmaat, Geok Wee Tan, Johanna A.A. Bult, Yujie Zhong, Wouter J. Plattel, Rogier Mous, Pim Mutsaers, Wendy B.C. Stevens, Joost S.P. Vermaat, Martine E.D. Chamuleau, Arjan Diepstra, Anke Van Den Berg, Filipe Montes De Jesus, Marcel Nijland
Journal: Blood
Blood (2022) 140 (Supplement 1): 9274–9276.
https://doi.org/10.1182/blood-2022-171213
Published: 2022
Journal Articles

Tumor Microenvironment Determinants of Immunotherapy Response Identified By Integrated Host & Viral Analysis of Post-Transplant Lymphoproliferative Disorders

Joseph Schroers-Martin, Andrea Garofalo, Joanne Soo, Jan Boegeholz, Stefan K. Alig, Brian Sworder, Chih Long Liu, Helen Luikart, Gerardo Gamino, DP Morales, Kathrin Freystätter, James Hamilton, III, David M. Kurtz, Seth Hollander, David Rosenthal, Gundeep Dhillon, Jayant Raikhelkar, Stijn Verleden, Marcel Nijland, Sean Agbor-Enoh, Martin Andreas, Abdallah Kfoury, Heather Ross, Lorenzo Zaffiri, Yasodha Natkunam, Maximilian Diehn, Kiran Khush, Ash A. Alizadeh
Journal: Blood
Blood (2022) 140 (Supplement 1): 172–174.
https://doi.org/10.1182/blood-2022-158647
Published: 2022
Journal Articles

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Ruben A.L. De Groen, Fleur A De Groot, Lorraine M. De Haan, Tom van Wezel, Troy Noordenbos, Stefan Boehringer, Ronald Van Eijk, Richard Raghoo, Dina Ruano, Aniko Sijs-Szabo, Liane te Boome, Valeska Terpstra, Henriette Levenga, Aline Nicolae, Ward Posthuma, Isabelle Focke-Snieders, Lizan Hardi, Wietske den Hartog, Lara H. Böhmer, Anke Van Den Berg, Pim Mutseaers, Marjolein W.M. Van Der Poel, Myrurgia Abdul Hamid, F.J. Sherida H. Woei-a-Jin, Ann Janssens, Thomas Tousseyn, Judith Bovée, Hendrik Veelken, Steven T Pals, Arjan Diepstra, Marcel Nijland, Marie José Kersten, Patty M. Jansen, Arjen Cleven, Joost S.P. Vermaat
Journal: Blood
Blood (2022) 140 (Supplement 1): 3534–3536.
https://doi.org/10.1182/blood-2022-159036
Published: 2022
Journal Articles

Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma

Ymke van der Pol, Steven Wang, Norbert Moldovan, A.Vera de Jonge, Esther E.E. Drees, Margaretha Roemer, Bauke Ylstra, Marcel Nijland, Marjolein W.M. Van Der Poel, Koen de Heer, Clara Klerk, Rozemarijn van Rijn, Rob Fijnheer, Vibeke K.J. Vergote, Aart Beeker, Laurens Nieuwenhuizen, Rogier Mous, Joost S.P. Vermaat, D. Michiel Pegtel, Martine E.D. Chamuleau, Florent Mouliere
Journal: Blood
Blood (2022) 140 (Supplement 1): 3529–3531.
https://doi.org/10.1182/blood-2022-168668
Published: 2022
Journal Articles

Plasma Extracellular Vesicle-Associated microRNAs for Early Response Prediction in Patients with High-Grade B-Cell Lymphoma

Steven Wang, Esther E.E. Drees, Cristina Gómez-Martín, A. De Jonge, Monique van Eijndhoven, Nils Groenewegen, Sandra Veldt-Verkuijlen, Marcel Nijland, Marjolein W.M. Van Der Poel, Yorick Sandberg, Rozemarijn van Rijn, Pim Mutsaers, Vibeke K.J. Vergote, Marie José Kersten, Yavuz M. Bilgin, Wendy B.C. Stevens, Marc Durian, Tjeerd J.F. Snijders, Daphne de Jong, Josée M. Zijlstra, Martine E.D. Chamuleau, Dirk Michiel Pegtel
Journal: Blood
Blood (2022) 140 (Supplement 1): 3523–3524.
https://doi.org/10.1182/blood-2022-165494
Published: 2022
Journal Articles

A Propensity Score-Adjusted Comparison of Lenalidomide + R-CHOP Versus R-CHOP for MYC -Rearranged DLBCL Patients

A. Vera de Jonge, Erik D. van Werkhoven, Avinash G. Dinmohamed, Marcel Nijland, Aeilko H. Zwinderman, Patrick M. Bossuyt, Martine S. Veldhuis, Emma G.G.M. Rutten, Rogier Mous, Joost S.P. Vermaat, Yorick Sandberg, Eva de Jongh, Yavuz M. Bilgin, Rinske Boersma, Harry R. Koene, Marie Jose Kersten, Daphne de Jong, Martine E.D. Chamuleau
Journal: Blood
Blood (2022) 140 (Supplement 1): 2059–2060.
https://doi.org/10.1182/blood-2022-163204
Published: 2022
Journal Articles

Subcutaneous Epcoritamab + R-Dhax/C in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Eligible for Autologous Stem Cell Transplant: Updated Phase 1/2 Results

Pau Abrisqueta, Raul Cordoba, Lorenzo Falchi, Sven de Vos, Marcel Nijland, Fritz Offner, Jun Wu, Irina Bykhovski, Liwei Wang, Ali Rana, Tycel Phillips
Journal: Blood
Blood (2022) 140 (Supplement 1): 1068–1069.
https://doi.org/10.1182/blood-2022-158278
Published: 2022
Journal Articles

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

Clinical Trials & Observations
Mirian Brink, Frederik O. Meeuwes, Marjolein W. M. van der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G. N. J. Mutsaers, Lara H. Böhmer, F. J. Sherida H. Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Wouter Plattel, Gerwin A. Huls, Joost S. P. Vermaat, Marcel Nijland
Journal: Blood
Blood (2022) 140 (9): 1009–1019.
https://doi.org/10.1182/blood.2021015114
Published: 2022
Includes: Supplemental data